OM

Omar Megahed

Ouvert aux possibilités

Finance Manager | Strategic Financial Analysis

Ontario, ON

Toronto Metropolitan University (formerly Ryerson)

À propos

Finance professional with a track record in strategic financial analysis, corporate controlling, and executive reporting across multi-entity, multinational operations — advising CFOs and cross-functional leadership on planning, cost optimization, and M&A due diligence in a consulting-style advisory capacity. Experienced in IFRS-compliant close processes and automating forecasting workflows in Excel/VBA and Power BI. Seeking to bring strategic advisory expertise, M&A due diligence, and margin/DSO optimization to a global finance team.

Compétences

  • Power BI
  • Tableau

Expérience

  1. Senior Controller

    GMED Holdings (EG Medical Systems)

    mai 2025 to juill. 2026

    Cairo, Egypt

    • Led strategic financial analysis and monthly financial closings, consolidating P&L statements across 72 business lines during a leadership transition, supported by the Head of Accounting and CFO. • Directed cost optimization and M&A financial modeling and due diligence for the acquisition of Philips' East Africa operations, evaluating asset portfolios to support executive proposals for international funding (including World Bank/IFC frameworks). • Restructured commercial contract payment terms and cost recovery models, accelerating working capital turnarounds and reducing Days Sales Outstanding (DSO) by 15%, collaborating across finance and commercial teams while enforcing tight payment terms for currency risk.

  2. Financial Analyst

    GMED Holdings (EG Medical Systems)

    nov. 2021 to mai 2025

    Cairo, Egypt

    • Drove annual OPEX/CAPEX planning cycles across entire corporate umbrella including 2 manufacturing facilities, collaborating with cross-functional finance managers on standard costing allocations and factory overhead absorption. • Engineered automated Power BI dashboards and Excel VBA forecasting models, cutting monthly executive reporting cycle times from 10 days to 7-8 and improving data delivery for leadership decision-making. • Led Price-Volume-Mix (PVM) variance analysis and financial efficiency reviews with discount controls across 10,000 SKU's to determine where growth was originating during an inflation period. • Compiled executive reporting packages (Sales, GP, OPEX Bridges, DSO, DSI) and quarterly disclosures for international partner Fresenius Medical Care (Germany) — direct experience in multinational stakeholder reporting. • Evaluated DCF and payback feasibility for new manufacturing line investments while monitoring Days Sales of Inventory (DSI) to improve balance sheet liquidity.

  3. Rotational Intern

    GMED Holdings (EG Medical Systems)

    mai 2019 to sept. 2019

    Cairo, Egypt

    • Completed structured rotations across sales, accounting, controlling, and treasury departments

Formation

  1. Toronto Metropolitan University (formerly Ryerson)

    Bachelor of Commerce Honours, Finance Major, Economics Minor

    Toronto

    2016 to 2021